Literature DB >> 17877920

Alcohol and atherosclerosis: recent insights.

Janne Tolstrup1, Morten Grønbaek.   

Abstract

Light to moderate alcohol intake is known to have cardioprotective properties; however, the magnitude of protection depends on other factors and may be confined to some subsets of the population. This review focuses on factors that modify the relationship between alcohol and coronary heart disease (CHD). The cardioprotective effect of alcohol seems to be larger among middle-aged and elderly adults than among young adults, who do not have a net beneficial effect of a light to moderate alcohol intake in terms of reduced all-cause mortality. The levels of alcohol at which the risk of CHD is lowest and the levels of alcohol at which the risk of CHD exceeds the risk among abstainers are lower for women than for men. The pattern of drinking seems important for the apparent cardioprotective effect of alcohol, and the risk of CHD is generally lower for steady versus binge drinking. Finally, there is some evidence that wine may have more beneficial effects than beer and distilled spirits; however, these results are still controversial and may be confounded by personal characteristics and other lifestyle factors such as diet. The inverse association between alcohol intake and CHD is influenced by age, gender, drinking pattern, and possibly by type of alcohol.

Entities:  

Mesh:

Year:  2007        PMID: 17877920     DOI: 10.1007/s11883-007-0007-6

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  47 in total

1.  Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study.

Authors:  P Boffetta; L Garfinkel
Journal:  Epidemiology       Date:  1990-09       Impact factor: 4.822

2.  By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease?

Authors:  M R Law; J K Morris
Journal:  Eur J Clin Nutr       Date:  1998-08       Impact factor: 4.016

3.  How much alcohol and how often? Population based case-control study of alcohol consumption and risk of a major coronary event.

Authors:  P McElduff; A J Dobson
Journal:  BMJ       Date:  1997-04-19

4.  Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine.

Authors:  E N Frankel; J Kanner; J B German; E Parks; J E Kinsella
Journal:  Lancet       Date:  1993-02-20       Impact factor: 79.321

5.  Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine.

Authors:  A S St Leger; A L Cochrane; F Moore
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

6.  Better psychological functioning and higher social status may largely explain the apparent health benefits of wine: a study of wine and beer drinking in young Danish adults.

Authors:  E L Mortensen; H H Jensen; S A Sanders; J M Reinisch
Journal:  Arch Intern Med       Date:  2001 Aug 13-27

7.  Alcohol consumption, drinking pattern and acute myocardial infarction. A case referent study based on the Swedish Twin Register.

Authors:  N Hammar; A Romelsjö; L Alfredsson
Journal:  J Intern Med       Date:  1997-02       Impact factor: 8.989

8.  Wines and grape juices as modulators of platelet aggregation in healthy human subjects.

Authors:  C R Pace-Asciak; O Rounova; S E Hahn; E P Diamandis; D M Goldberg
Journal:  Clin Chim Acta       Date:  1996-03-15       Impact factor: 3.786

9.  Alcohol consumption and mortality: modelling risks for men and women at different ages.

Authors:  Ian R White; Dan R Altmann; Kiran Nanchahal
Journal:  BMJ       Date:  2002-07-27

10.  Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.

Authors:  Kenneth J Mukamal; Katherine M Conigrave; Murray A Mittleman; Carlos A Camargo; Meir J Stampfer; Walter C Willett; Eric B Rimm
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

View more
  4 in total

1.  ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.

Authors:  C Noel Bairey Merz; Mark J Alberts; Gary J Balady; Christie M Ballantyne; Kathy Berra; Henry R Black; Roger S Blumenthal; Michael H Davidson; Sara B Fazio; Keith C Ferdinand; Lawrence J Fine; Vivian Fonseca; Barry A Franklin; Patrick E McBride; George A Mensah; Geno J Merli; Patrick T O'Gara; Paul D Thompson; James A Underberg
Journal:  J Am Coll Cardiol       Date:  2009-09-29       Impact factor: 24.094

2.  Adopting moderate alcohol consumption in middle age: subsequent cardiovascular events.

Authors:  Dana E King; Arch G Mainous; Mark E Geesey
Journal:  Am J Med       Date:  2008-03       Impact factor: 4.965

3.  Cardiovascular disease risk factors in homeless people.

Authors:  Margit Kaldmäe; Mihkel Zilmer; Margus Viigimaa; Galina Zemtsovskaja; Karel Tomberg; Tanel Kaart; Margus Annuk
Journal:  Ups J Med Sci       Date:  2011-06-22       Impact factor: 2.384

Review 4.  Particle-induced pulmonary acute phase response may be the causal link between particle inhalation and cardiovascular disease.

Authors:  Anne T Saber; Nicklas R Jacobsen; Petra Jackson; Sarah Søs Poulsen; Zdenka O Kyjovska; Sabina Halappanavar; Carole L Yauk; Håkan Wallin; Ulla Vogel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2014-06-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.